Document and Entity Information
Document and Entity Information | Dec. 01, 2020 |
Document and Entity Information [Abstract] | |
Document Type | 8-K |
Document Period End Date | Dec. 1, 2020 |
Entity File Number | 001-37635 |
Entity Registrant Name | Axsome Therapeutics, Inc. |
Entity Incorporation, State or Country Code | DE |
Entity Tax Identification Number | 45-4241907 |
Entity Address, Address Line One | 22 Cortlandt Street, 16th Floor |
Entity Address, City or Town | New York |
Entity Address, State or Province | NY |
Entity Address, Postal Zip Code | 10007 |
City Area Code | 212 |
Local Phone Number | 332-3241 |
Written Communications | false |
Soliciting Material | false |
Pre-commencement Tender Offer | false |
Pre-commencement Issuer Tender Offer | false |
Title of 12(b) Security | Common Stock, Par Value $0.0001 Per Share |
Trading Symbol | AXSM |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | true |
Entity Central Index Key | 0001579428 |
Amendment Flag | false |